Home » Newsletters » BioWorld Science

BioWorld Science

June 23, 2022

View Archived Issues

EGFRvIII T-cell bispecific antibody activity in glioblastoma models

Biodistribution and efficacy of [177Lu]rhPSMA-10.1 compared to [177Lu]PSMA-I&T in prostate cancer

New P2X purinoceptor 3 antagonists discovered at Chiesi

Roche synthesizes new HBV HBsAg and HBeAg inhibitors

Katholieke Universiteit Leuven describes new TRPM3 antagonists

Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical patent TLR7/8/9 antagonists

Pfizer identifies compounds targeting transthyretin

A novel Smad4-mutated mouse model of Myhre Syndrome

Novel virus-like vaccine candidate against HERV-K shows promise in preclinical breast cancer

FGFR and PDGFR as targets for CNS tumors with BCOR alterations

Data in mice support potential of ATL-1102 for limb girdle muscular dystrophy R2

VPAC receptor-specific Cu-67-TP-3805 shows theranostic potential for prostate cancer

CAIX-targeting radiopeptides show promise in preclinical models of cancer

Mindset Pharma collaborates with CAMH on preclinical evaluation of MSP-1014

Apellis and Affilogic expand R&D collaboration to include Nanofitins targeting TfR

Inhibitor harms leukemic stem cells while boosting normal ones

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...